紅斑性狼瘡(Lupus erythematosus)
全身性紅斑狼瘡(systemic lupus erythematosus,簡稱SLE)也叫系統性紅斑狼瘡
In SLE(systemic lupus erythematosus), increased levels of IL-18 have been found
在SLE(系統性紅斑狼瘡)中,發現IL-18水平升高
Virtually, all papers indicate that IL-17 production is increased in patients with SLE as well as
in animals with lupus-like diseases.
實際上,所有論文表明,SLE患者以及狼瘡樣疾病的動物中IL-17的產生增加。
能降低IL-18、IL-17:硒、維它命C、輔酶Q10、維生素D、維生素E
Intriguingly, the percentage level of FoxP3 on CD4+CD25high cells was significantly decreased in SLE
patients with active disease (2.9 +/- 1.05) when compared with those with inactive SLE (3.5 +/- 0.8)
and control groups (4.7 +/- 1.2) (P < 0.05).
有趣的是,與無活性SLE和對照組相比,SLE患者的活動性疾病,FoxP3在CD4 + CD25高細胞的百分比水平顯著降低。
Our data revealed impaired production of Tregs in SLE patients
我們的數據顯示SLE患者的Tregs生產受損
大量研究表明 Foxp3+調節性 T 細胞(CD4+Treg)具有免疫調節作用
硒上調了Treg 細胞、Foxp3 mRNA 表達
維生素C能阻止Foxp3下調
經EGCG(兒茶素)治療後Foxp3+T細胞比例顯著增加
Serum 25(OH)D levels significantly increased under vitamin D supplementation (p = 0.001).
補充維生素D時血清25(OH)D水平顯著升高。
The FoxP3+/IL-17A ratio in SLE patients after 6 months of vitamin D supplementation was higher than
that in the baseline
維生素D補充6個月後SLE患者的FoxP3 + / IL-17A比例高於基線
CoQ10 treatment increased the expression of p-AMPK and FOXP3
輔酶Q10(CoQ10)處理增加了FOXP3的表達